NIH-funded research R01 grant

Exploring how different forms of a protein affect bone growth

Official title: Different Roles for Colony Stimulating Factor 1 Isoforms in Anabolic Therapy for Low Bone Mass

Funded at Yale University · NIH-10883549 · Data updated 2026-11-12

This study is looking at how two types of a protein called Colony Stimulating Factor 1 can help bones grow better when a hormone called PTH is present, which could lead to new treatments for people with low bone mass.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionYale University
NIH-funded
Lab location1 site (New Haven, United States)
Project startJuly 10, 2023
Project endJune 30, 2028
Funding year2024
Award (this year)$639,520
NIH project number5R01AR081074-02
Project IDNIH-10883549 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals at risk for osteoporosis or other conditions that lead to low bone mass.

Less likely to help

Patients with normal bone density or those not affected by bone metabolism disorders may not benefit from this research.

What this research studies

This research investigates the roles of two different forms of Colony Stimulating Factor 1 (CSF1) in promoting bone growth in response to a hormone called PTH. The study uses animal models to understand how these forms of CSF1 interact with bone cells, particularly focusing on how they influence the activity of osteoclasts, which are cells that break down bone. By examining the effects of these CSF1 isoforms, the research aims to uncover mechanisms that could enhance bone formation and potentially lead to new therapies for low bone mass conditions.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that significantly improve bone density and health for patients with low bone mass.

How similar studies have gone: Previous research has shown promising results in understanding the roles of CSF1 in bone metabolism, suggesting that this approach has potential for significant advancements.

Where this research is happening

  • Yale University
    New Haven, United States
    Active

Researchers

  • Principal investigator: Insogna, Karl Leonard — Yale University
  • Study coordinator: Insogna, Karl Leonard

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.